From the 5th to the 7th of June, the 29th Conference of the European Wound Management Association took place in Gothenburg and gathered the European and international wound management communities with the common goal of improving the care of wound patients.
Histocell took part as exhibitor, as well as in the scientific programme with the presentation of the poster “Control of oxidative stress to activate non-healing wounds: case series”. The poster describes 34 non-healing wounds from different etiologies treated with Reoxcare, where Reoxcare effectively contributed to overcome the inflammatory phase, induced granulation tissue formation and the activation of wound edges.
Being the largest wound care conference in Europe, EWMA gave us the opportunity to meet many visitors who could know more about Reoxcare and the oxidative stress. Potential users reached us for information and some very interesting meetings were held with potential distributors from different countries.
Reoxcare® is an antioxidant wound dressing with ingredients from natural origin, unique within the range of products so far used for the treatment of chronic wounds. With more than 30 preclinical and clinical studies carried out, Reoxcare® has demonstrated unique antioxidant properties and the ability to induce a natural healing in highly inflammatory environments, the main cause of chronification of wounds such as vascular origin ulcers or pressure ulcers, and has demonstrated to be particularly effective in diabetic foot ulcers.
Chronic wounds are a serious health and economic problem worldwide. It is estimated that there are about 175 million new cases every year, including pressure ulcers, vascular or diabetic. 28 million people suffer from chronic wounds annually and the estimated market this year for the treatment of these injuries is more than 5,000 million euros.